<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-30215" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Tissue and Organ Donation</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Muco</surname>
            <given-names>Erind</given-names>
          </name>
          <aff>Campbell University School of Osteopathic Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Yarrarapu</surname>
            <given-names>Siva Naga S.</given-names>
          </name>
          <aff>Monmouth Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Douedi</surname>
            <given-names>Hani</given-names>
          </name>
          <aff>Philadelphia College</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Burns</surname>
            <given-names>Bracken</given-names>
          </name>
          <aff>East Tennessee State University (ETSU)</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Erind Muco declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Siva Naga Yarrarapu declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Hani Douedi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Bracken Burns declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>24</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-30215.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Tissue/organ donation is a complex and multidisciplinary process that begins with the meticulous procedure of determining death. This is followed by a specific set of inclusion/exclusion criteria that determine if organs can/cannot be procured from the donor. Ultimately, this leads to a multi-specialty surgery of procurement and transplantation. This activity outlines the evaluation and management of the donation process and highlights the role of the healthcare team in managing patients post-transplant.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Discuss interprofessional team strategies for improving care coordination and communication to advance organ donation and improve outcomes.</p></list-item><list-item><p>Summarize the barriers to tissue and organ donation.</p></list-item><list-item><p>Review the role of the healthcare team in tissue and organ donation.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30215&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30215">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-30215.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Tissues and organs are procurable from a living or deceased donor. Live donation involves either kidney, partial liver, or lung. The Institute of Medicine - American National Academy of Sciences clarified that&#x000a0;a clinician could declare death using either neurologic criteria or circulatory criteria.&#x000a0;<xref ref-type="bibr" rid="article-30215.r1">[1]</xref>&#x000a0;Following such determination, select organ(s) may be procured from the donor and then transplanted into a host.</p>
        <p>Sadly, every day, patients suffer morbidity or mortality due to a lack of availability of tissue or an organ transplant.&#x000a0;<xref ref-type="bibr" rid="article-30215.r2">[2]</xref><xref ref-type="bibr" rid="article-30215.r3">[3]</xref><xref ref-type="bibr" rid="article-30215.r4">[4]</xref><xref ref-type="bibr" rid="article-30215.r2">[2]</xref>&#x000a0;Health professionals are often in a position to encourage families to make the difficult decision at the time of death of their loved one, to give the gift of life to another human, by donating tissues or organs.&#x000a0;<xref ref-type="bibr" rid="article-30215.r5">[5]</xref></p>
        <p>There are numerous challenges to organ donation, especially at a time when the family is grieving. Further, few patients have discussed the issue with their families, as such, they may not be able to anticipate the desires of their passing family member.</p>
        <p>Health providers must have the education to address family misconceptions and assist the team in donation recovery, preservation, and placement of tissues and organs from deceased and living donors. By educating practitioners about tissue and organ donation, more families will make the decision to donate and decrease the number of patients that pass due to lack of tissues or organs.</p>
      </sec>
      <sec id="article-30215.s3" sec-type="Function">
        <title>Function</title>
        <p>Tissue and organ donation is of tremendous benefit to living patients as it functions to help the living. One individual's tissue and organ donation can impact numerous lives. While the majority of the public is in favor of organ donation, individuals often fail to include this decision in their living wills. Further, while many states allow drivers to register as organ donors on their driver licenses, few complete the required form. The consequence is a tremendous tissue and organ shortage leading to long wait times on transplant lists that in many instances result in premature deaths of viable patients that could have lived longer lives with the benefit of tissue and organ transplants.</p>
      </sec>
      <sec id="article-30215.s4" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>Care during the organ donation process is multi-faceted and begins with the optimization of the donor following the determination of death using neurologic or circulatory criteria. This process means optimizing cardiopulmonary status via hemodynamic and ventilatory support. Expeditious organ/tissue procurement is the recommendation because, soon after death, inflammatory mediators begin to invade solid organs leading to increased organ immunogenicity.&#x000a0;<xref ref-type="bibr" rid="article-30215.r6">[6]</xref>&#x000a0;While being cautious, from procurement to placement, every step must be done quickly and efficiently to assure the best outcomes.</p>
        <p>
<bold>Healthcare Provider and Team Role</bold>
</p>
        <p>Some health professionals have cultural, ethical, or religious beliefs that preclude their willingness to participate in the donation or receipt of tissues or organs. It is important to respect individuals' personal belief systems; however, personal beliefs should not interfere with the patient's right to self-determination. The primary commitment is to the patient and family. However, certain healthcare professionals may not wish to become involved in the organ and tissue donation process or to participate in campaigns to increase donations in their community and/or facility. This decision should be respected as a personal choice. For those that want to help, the role can be as simple as helping patients make the decision to donate prior to death.</p>
        <p>Tissue and organ removal teams' main concerns revolve around permission, removal, and rapid transfer of organs and tissues.&#x000a0;<xref ref-type="bibr" rid="article-30215.r1">[1]</xref><xref ref-type="bibr" rid="article-30215.r7">[7]</xref>&#x000a0;Challenges often involve failure to identify eligible donors, death not officially declared within a specific timeframe, or absence of an appropriate recipient.&#x000a0;</p>
        <p>Tissue and organ placement teams made concerns include the suitability of the tissue or organ, maintaining the viability of the tissue and organ, and rapid transplantation.&#x000a0;Permission issues may stem from the denial of organ donation from a potential donor, donor&#x02019;s family, or other judicial officers.&#x000a0;<xref ref-type="bibr" rid="article-30215.r8">[8]</xref><xref ref-type="bibr" rid="article-30215.r9">[9]</xref></p>
        <p>Health professional's responsibilities in tissue and organ donation vary with their role. Some providers work with the families of donors, others with the families of recipients. Some may be responsible for performing surgery and managing the patient. In addition, there is often an administrative team that works with organ procurement organizations. While health professionals should help educate patients on the benefits of organ donation, specific responsibilities of team members include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Organ donation public and provider education&#x000a0;<xref ref-type="bibr" rid="article-30215.r10">[10]</xref></p>
          </list-item>
          <list-item>
            <p>Organ donor identification&#x000a0;<xref ref-type="bibr" rid="article-30215.r11">[11]</xref></p>
          </list-item>
          <list-item>
            <p>Coordination of tissue and organ donation</p>
          </list-item>
          <list-item>
            <p>Support of donor and recipient families which includes understanding cultural, psychological, and religious issues</p>
          </list-item>
          <list-item>
            <p>Administration management and interaction with organ procurement organizations</p>
          </list-item>
        </list>
        <p>
<bold>Individuals that would like to become involved in tissue and organ donation can do the following steps:&#x000a0;</bold>
</p>
        <list list-type="order">
          <list-item>
            <p>Education by becoming familiar and involved with local organ procurement programs</p>
          </list-item>
          <list-item>
            <p>Complete continuing education in regards to organ donation procurement and placement and provide staff and colleague education</p>
          </list-item>
          <list-item>
            <p>Develop the skills to work with the organ procurement coordinator at your institution</p>
          </list-item>
        </list>
        <p>
<bold>Providers should be aware of the following in regards to tissue and organ procurement and placement:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>The first priority is to save the patients life, not harvest tissue or organs; organ donation is not permission to give up or withdraw care</p>
          </list-item>
          <list-item>
            <p>Most religions support tissue and organ donation</p>
          </list-item>
          <list-item>
            <p>There is no cost to the family for tissue or organ donation</p>
          </list-item>
          <list-item>
            <p>Matching of the donor to the recipient usually involves a computerized matching system that considers: recipients condition, blood type, wait time, and location; the financial situation of the recipient is not a factor</p>
          </list-item>
        </list>
        <p>
<bold>Tissue and Organ Selection and Processing</bold>
</p>
        <p>Members of the healthcare team should have a clear&#x000a0;understanding of the issues involved in tissue and organ donation as this will improve outcomes. Organ donation starts with confirmation of clinical brain death, usually by a neurosurgeon or neurologist.&#x000a0; It should be remembered that a coma is not brain death. In general, this is based on accepted medical standards:</p>
        <list list-type="order">
          <list-item>
            <p>Irreversible cessation of brain functions, including the brain stem&#x000a0;<xref ref-type="bibr" rid="article-30215.r12">[12]</xref><xref ref-type="bibr" rid="article-30215.r13">[13]</xref><xref ref-type="bibr" rid="article-30215.r14">[14]</xref></p>
          </list-item>
          <list-item>
            <p>Irreversible cessation of circulatory and respiratory functions</p>
          </list-item>
        </list>
        <p>Other considerations for death may include family or patient has signed an advanced directive to withdraw life support.</p>
        <p>When a prospective donor is near death or has died, the organ procurement coordinator should be notified and informed of the patient's identification number, name, age, past medical history, cause or anticipated cause of death, family contact information, and any other pertinent information. the organ procurement coordinator determines if the patient is a potential donor and should arrive at the hospital within 90 minutes if the patient is a suitable candidate. All deceased patients may be considered for organ donation. The coordinator, if the patient is acceptable, will then speak with the family and gain further information.</p>
        <p>If the evaluation rules in donation, the organ procurement coordinator will complete the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Arrange for additional tests</p>
          </list-item>
          <list-item>
            <p>Arrange for social work and clergy support</p>
          </list-item>
          <list-item>
            <p>Search the state registry to determine if prior consent has been given on the patient's driver's license</p>
          </list-item>
          <list-item>
            <p>If possible, the living will of the patient will be located and evaluated. If there is no predetermined consent, the coordinator will contact the spouse, certified domestic partner, adult child, parent, adult sibling, legal guardian, or any other person authorized to make decisions.</p>
          </list-item>
          <list-item>
            <p>Until a determination of donation is finalized, the coordinator will assure the patient is maintained on artificial life support.</p>
          </list-item>
          <list-item>
            <p>The coordinator procurement coordinator contacts the medical examiner and&#x000a0;Organ Procurement and national database Transplantation Network (OPTN) to initiate a search for potential matching recipients.</p>
          </list-item>
          <list-item>
            <p>Donor is matched with the recipient based on tissue type, blood type, weight, height, wait time, severity of illness, and distance. The system generates a matching recipient list by tissue/organ type for contact use by the coordinator.</p>
          </list-item>
          <list-item>
            <p>The first match for each tissue/organ becomes the prime transplant candidate for contact.</p>
          </list-item>
          <list-item>
            <p>The transplant surgeon makes the final decision based on recipient health, suitability of tissue or organ, and the availability of the recipient with local patients receiving preference.</p>
          </list-item>
          <list-item>
            <p>The receiving coordinator conducts consent and matching in a manner similar to organ donation.</p>
          </list-item>
          <list-item>
            <p>The donor body is placed in the morgue with saline-soaked gauze covering the eyes and is not released to the funeral home until all potential harvesting is completed.</p>
          </list-item>
          <list-item>
            <p>Recovery of tissue is performed by recovery surgeons either in the same hospital or at another location.</p>
          </list-item>
        </list>
        <p>
<bold>Tissue and Organ Recovery and Transplantation</bold>
</p>
        <p>Tissues that may be recovered and transplanted include blood vessels, bone, cartilage, corneas, heart valves, skin, and tendons. Organs that may be recovered and transplanted include the heart, intestine, kidney, liver, lung, and pancreas. Steps in the process include:</p>
        <list list-type="order">
          <list-item>
            <p>Appropriate consents from the family</p>
          </list-item>
          <list-item>
            <p>Rapid scheduling of the organ recovery surgical team by the organ procurement coordinator</p>
          </list-item>
          <list-item>
            <p>Preparation of an ice-cold preservation solution used to flush each organ removed</p>
          </list-item>
          <list-item>
            <p>Surgical removal using standard surgical incisions in a sterile operative environment</p>
          </list-item>
          <list-item>
            <p>Organs removed first and placed in sterile containers and packed icy slush which cools but does not freeze (kidneys are placed on a perfusion machine the pumps preservation fluid through the organ during transport)</p>
          </list-item>
          <list-item>
            <p>Following organ removal, tissues are recovered</p>
          </list-item>
          <list-item>
            <p>Any incisions made are surgically closed</p>
          </list-item>
          <list-item>
            <p>Due to rapid loss of viability of organs and tissues, rapid ground or air transport is arranged by the organ procurement coordinator</p>
          </list-item>
          <list-item>
            <p>The organ procurement coordinator contacts the funeral director for removal of the body</p>
          </list-item>
          <list-item>
            <p>The recipient transplant team of the donor organ or tissue, as well as the recipient, is made ready to receive and complete the transplant</p>
          </list-item>
        </list>
        <p>
<bold>Non-living Donors</bold>
</p>
        <p>Following donor optimization, standard organ removal in the operating room is as follows: heart and lungs first, followed by hepatectomy, pancreatectomy, and bilateral nephrectomies.&#x000a0;<xref ref-type="bibr" rid="article-30215.r15">[15]</xref>&#x000a0;Subsequent organ cooling to 4 degrees C considerably reduces warm ischemia damage to organs; however, it does not completely arrest cellular processes. Therefore, a thorough organ washout technique, along with selecting appropriate preservation solutions, is critical to organ viability leading to decreased immune reaction and formation of oxygen-free radicals upon reperfusion.&#x000a0;<xref ref-type="bibr" rid="article-30215.r16">[16]</xref></p>
        <p>
<bold>Living Donors</bold>
</p>
        <p>There are two types of living tissue and organ donation.</p>
        <list list-type="order">
          <list-item>
            <p>Directed donation - donor names a specific tissue or organ recipient</p>
          </list-item>
          <list-item>
            <p>Non-directed donation - donor does not name a specific tissue or organ recipient</p>
          </list-item>
        </list>
        <p>While living donation reduces transplant wait times, it has its own set of challenges.&#x000a0;The kidney and liver are commonly living donor donations. Less commonly intestines, lung, or pancreas segments are transplanted.&#x000a0;</p>
        <p>Considerations should be given to cost and potential complications.&#x000a0;Living donation requires informed consent due to potential complications. Some are specific to the organ donated. Complications include:</p>
        <p>
<bold>General</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Abdominal internal bleeding</p>
          </list-item>
          <list-item>
            <p>Allergic reactions to anesthesia</p>
          </list-item>
          <list-item>
            <p>Blood clots</p>
          </list-item>
          <list-item>
            <p>Blood loss</p>
          </list-item>
          <list-item>
            <p>Death</p>
          </list-item>
          <list-item>
            <p>Depression</p>
          </list-item>
          <list-item>
            <p>Infection</p>
          </list-item>
          <list-item>
            <p>Organ dysfunction</p>
          </list-item>
          <list-item>
            <p>Pain</p>
          </list-item>
          <list-item>
            <p>Pneumonia</p>
          </list-item>
          <list-item>
            <p>Wound infection</p>
          </list-item>
        </list>
        <p>
<bold>Kidney&#x000a0;</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Bowel obstruction</p>
          </list-item>
          <list-item>
            <p>Damaged kidney function require dialysis or transplantation</p>
          </list-item>
          <list-item>
            <p>Hernia</p>
          </list-item>
          <list-item>
            <p>Hypertension</p>
          </list-item>
        </list>
        <p>
<bold>Liver </bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Bile leakage</p>
          </list-item>
          <list-item>
            <p>Bowel obstruction</p>
          </list-item>
          <list-item>
            <p>Damaged liver function requiring medical therapy or transplantation</p>
          </list-item>
          <list-item>
            <p>Hernia</p>
          </list-item>
        </list>
        <p>
<bold>Barriers and Misunderstands Concerning Tissue and Organ Donation</bold>
</p>
        <p>Health professionals should be educated in tissue and organ donation and be prepared to provide families with accurate information while dispelling misunderstandings.&#x000a0;<xref ref-type="bibr" rid="article-30215.r17">[17]</xref></p>
        <p>
<bold>Barriers</bold>
</p>
        <p>There are numerous barriers to organ donation and recovery. Health professionals and institutions should provide an experienced team to make the process of tissue and organ donation as efficient as possible while minimizing the emotional impact on donor families. The team often consists of a nurse, a social worker or pastor, and a clinical provider. If the institution provides positive moral and social support, the donation for the family usually proves to be a rewarding experience.</p>
        <p>There is a potential cost of living donation. While insurance may cover the surgery and follow-up care, any long-term complications may not necessarily be covered. Uncovered costs include lost wages, particularly if there are long-term complications of surgery.&#x000a0;<xref ref-type="bibr" rid="article-30215.r18">[18]</xref><xref ref-type="bibr" rid="article-30215.r19">[19]</xref><xref ref-type="bibr" rid="article-30215.r18">[18]</xref></p>
        <p>
<bold>Misunderstandings</bold>
</p>
        <p>Many clinicians and families may have misunderstandings in regards to tissue and organ donation. Examples include a belief that there is an age limit, when in fact there is no age limit on organ donation. Others are concerned it may be a religious violation when in reality few religions prohibit tissue and organ donation. Others are concerned that an open casket may not be possible when this typically is not an issue. Some believe that the health of the donor may prohibit donation, in reality, few medical conditions affect tissue or organ donation. For some donor families, they believe there is a cost associated when no fees are levied. Some even believe the organs are sold, in reality, organs are matched via a computer database which does not consider the financial status of potential recipients. Patients may not agree to donate because they believe health professionals will be less apt to save them in an emergency, when in fact saving their life is the top priority, and tissue and organ donation is not considered.&#x000a0;<xref ref-type="bibr" rid="article-30215.r17">[17]</xref></p>
      </sec>
      <sec id="article-30215.s5" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Following successful transplantation into a host, the mainstay of long-term care is a combination of lifelong close monitoring and appropriate immunosuppression.&#x000a0;<xref ref-type="bibr" rid="article-30215.r20">[20]</xref><xref ref-type="bibr" rid="article-30215.r21">[21]</xref><xref ref-type="bibr" rid="article-30215.r22">[22]</xref>&#x000a0;Patients must come to realize that there will never come a time in their lives when close monitoring is no longer necessary. Additionally, clinicians must understand current standard practices in caring for these patients as well as accept upcoming innovations such as monitoring patients for donor-specific antibodies as a marker of immunologic risk.&#x000a0;<xref ref-type="bibr" rid="article-30215.r23">[23]</xref><xref ref-type="bibr" rid="article-30215.r24">[24]</xref>&#x000a0;Furthermore, non-invasive markers found in blood and urine are now beginning to replace biopsies in assessing for immunologic injury.&#x000a0;<xref ref-type="bibr" rid="article-30215.r25">[25]</xref><xref ref-type="bibr" rid="article-30215.r26">[26]</xref></p>
        <p>Organ donation is vital to patients, yet there is a large deficiency of those willing to donate coupled with a long list of individuals needing tissue and organ donation. By becoming educated regarding the issues and concerns, hopefully, more patients will successfully be encouraged to give the gift of life.</p>
      </sec>
      <sec id="article-30215.s6" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>For a successful tissue/organ transplantation to occur, it requires an extraordinary amount of teamwork from all aspects of the healthcare system. Preoperatively, nurses are required to provide close monitoring of hemodynamic parameters outlined in current standard practices and offer interventions as necessary. Intraoperatively, it is known that various specialties of medicine participate in the operation, requiring extensive and clear communication for surgical success. Finally, allied health professionals play a critical role in maximizing the organ recipient&#x02019;s return to normal function postoperatively, leading to a happy and healthy life.</p>
      </sec>
      <sec id="article-30215.s7" sec-type="Nursing, Allied Health, and Interprofessional Team Interventions">
        <title>Nursing, Allied Health, and Interprofessional Team Interventions</title>
        <p>Communication is a useful tool that is imperative to positive patient outcomes as it relates to organ transplantation. Research participants recognize that nurses are at the center of communication, seeing as they spend the most time at the bedside amongst all healthcare providers.&#x000a0;<xref ref-type="bibr" rid="article-30215.r27">[27]</xref>&#x000a0;As such, they become the most powerful means of communicating compliance and good practices to patients during their life-long journey of close monitoring, which involves close screening of infections, organ rejection, and malignancies.&#x000a0;</p>
      </sec>
      <sec id="article-30215.s8">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30215&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30215">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/30215/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=30215">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-30215.s9">
        <title>References</title>
        <ref id="article-30215.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thuong</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ruiz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Evrard</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kuiper</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Boffa</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Akhtar</surname>
                <given-names>MZ</given-names>
              </name>
              <name>
                <surname>Neuberger</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ploeg</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>New classification of donation after circulatory death donors definitions and terminology.</article-title>
            <source>Transpl Int</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>29</volume>
            <issue>7</issue>
            <fpage>749</fpage>
            <page-range>749-59</page-range>
            <pub-id pub-id-type="pmid">26991858</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30215.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hollander</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Nandi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bansal</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Godown</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zafar</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Rosenthal</surname>
                <given-names>DN</given-names>
              </name>
              <name>
                <surname>Lorts</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jeewa</surname>
                <given-names>A</given-names>
              </name>
              <collab>ACTION Network</collab>
            </person-group>
            <article-title>A coordinated approach to improving pediatric heart transplant waitlist outcomes: A summary of the ACTION November 2019 waitlist outcomes committee meeting.</article-title>
            <source>Pediatr Transplant</source>
            <year>2020</year>
            <month>Nov</month>
            <volume>24</volume>
            <issue>7</issue>
            <fpage>e13862</fpage>
            <pub-id pub-id-type="pmid">32985785</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30215.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tennankore</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Gunaratnam</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Suri</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Yohanna</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tangri</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Prasad</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gogan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rockwood</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Doucette</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sills</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kiberd</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Keough-Ryan</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>West</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Vinson</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Frailty and the Kidney Transplant Wait List: Protocol for a Multicenter Prospective Study.</article-title>
            <source>Can J Kidney Health Dis</source>
            <year>2020</year>
            <volume>7</volume>
            <fpage>2054358120957430</fpage>
            <pub-id pub-id-type="pmid">32963793</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30215.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bakhtiyar</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Godfrey</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Ahmed</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lamba</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Morgan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Loor</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Civitello</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cheema</surname>
                <given-names>FH</given-names>
              </name>
              <name>
                <surname>Etheridge</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>Goss</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rana</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Survival on the Heart Transplant Waiting List.</article-title>
            <source>JAMA Cardiol</source>
            <year>2020</year>
            <month>Nov</month>
            <day>01</day>
            <volume>5</volume>
            <issue>11</issue>
            <fpage>1227</fpage>
            <page-range>1227-1235</page-range>
            <pub-id pub-id-type="pmid">32785619</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30215.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mahmud</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Selection for Liver Transplantation: Indications and Evaluation.</article-title>
            <source>Curr Hepatol Rep</source>
            <year>2020</year>
            <volume>19</volume>
            <issue>3</issue>
            <fpage>203</fpage>
            <page-range>203-212</page-range>
            <pub-id pub-id-type="pmid">32837824</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30215.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Todd</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Jerome</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Jarquin-Valdivia</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Organ preservation in a brain dead patient: information support for neurocritical care protocol development.</article-title>
            <source>J Med Libr Assoc</source>
            <year>2007</year>
            <month>Jul</month>
            <volume>95</volume>
            <issue>3</issue>
            <fpage>238</fpage>
            <page-range>238-45</page-range>
            <pub-id pub-id-type="pmid">17641753</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30215.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Israni</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Zaun</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bolch</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rosendale</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Snyder</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Kasiske</surname>
                <given-names>BL</given-names>
              </name>
            </person-group>
            <article-title>Deceased Organ Donation.</article-title>
            <source>Am J Transplant</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>16 Suppl 2</volume>
            <fpage>195</fpage>
            <page-range>195-215</page-range>
            <pub-id pub-id-type="pmid">26755269</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30215.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jericho</surname>
                <given-names>BG</given-names>
              </name>
            </person-group>
            <article-title>Organ Donation After Circulatory Death: Ethical Issues and International Practices.</article-title>
            <source>Anesth Analg</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>128</volume>
            <issue>2</issue>
            <fpage>280</fpage>
            <page-range>280-285</page-range>
            <pub-id pub-id-type="pmid">29787408</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30215.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Freeman</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Bernat</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Ethical issues in organ transplantation.</article-title>
            <source>Prog Cardiovasc Dis</source>
            <year>2012</year>
            <season>Nov-Dec</season>
            <volume>55</volume>
            <issue>3</issue>
            <fpage>282</fpage>
            <page-range>282-9</page-range>
            <pub-id pub-id-type="pmid">23217432</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30215.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sandiumenge</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lomero Martinez</surname>
                <given-names>MDM</given-names>
              </name>
              <name>
                <surname>S&#x000e1;nchez Ib&#x000e1;&#x000f1;ez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Seoane Pillado</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Monta&#x000f1;a-Carreras</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Molina-Gomez</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Llaurad&#x000f3;-Serra</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dominguez-Gil</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Masnou</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bodi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pont</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Online education about end-of-life care and the donation process after brain death and circulatory death. Can we influence perception and attitudes in critical care doctors? A prospective study.</article-title>
            <source>Transpl Int</source>
            <year>2020</year>
            <month>Nov</month>
            <volume>33</volume>
            <issue>11</issue>
            <fpage>1529</fpage>
            <page-range>1529-1540</page-range>
            <pub-id pub-id-type="pmid">32881149</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30215.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jeong</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>YJ</given-names>
              </name>
            </person-group>
            <article-title>Effect of a multidisciplinary program to improve organ donation in the emergency department.</article-title>
            <source>Eur J Emerg Med</source>
            <year>2021</year>
            <month>Jan</month>
            <day>01</day>
            <volume>28</volume>
            <issue>1</issue>
            <fpage>58</fpage>
            <page-range>58-63</page-range>
            <pub-id pub-id-type="pmid">32976312</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30215.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Paix&#x000e3;o</surname>
                <given-names>JTC</given-names>
              </name>
              <name>
                <surname>Nascimento</surname>
                <given-names>VHND</given-names>
              </name>
              <name>
                <surname>Alves</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Rodrigues</surname>
                <given-names>MFA</given-names>
              </name>
              <name>
                <surname>Sousa</surname>
                <given-names>EJS</given-names>
              </name>
              <name>
                <surname>Santos-Lobato</surname>
                <given-names>BLD</given-names>
              </name>
            </person-group>
            <article-title>Analysis of brain death declaration process and its impact on organ donation in a reference trauma center.</article-title>
            <source>Einstein (Sao Paulo)</source>
            <year>2020</year>
            <volume>18</volume>
            <fpage>eAO5448</fpage>
            <pub-id pub-id-type="pmid">32965298</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30215.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Frenette</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Williamson</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Weiss</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Rochwerg</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ball</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Brindamour</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Serri</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>D'Aragon</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Meade</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>Charbonney</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Worldwide management of donors after neurological death: a systematic review and narrative synthesis of guidelines.</article-title>
            <source>Can J Anaesth</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>67</volume>
            <issue>12</issue>
            <fpage>1839</fpage>
            <page-range>1839-1857</page-range>
            <pub-id pub-id-type="pmid">32949008</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30215.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matar</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Wichmann</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kenney</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Subramanian</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ratcliff</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Tracy</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Gelbard</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <article-title>Outcomes and implications of a single brain death examination policy on organ donation outcomes at a high-volume trauma center.</article-title>
            <source>J Trauma Acute Care Surg</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>89</volume>
            <issue>6</issue>
            <fpage>1166</fpage>
            <page-range>1166-1171</page-range>
            <pub-id pub-id-type="pmid">32796440</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30215.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Young</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Matta</surname>
                <given-names>BF</given-names>
              </name>
            </person-group>
            <article-title>Anaesthesia for organ donation in the brainstem dead--why bother?</article-title>
            <source>Anaesthesia</source>
            <year>2000</year>
            <month>Feb</month>
            <volume>55</volume>
            <issue>2</issue>
            <fpage>105</fpage>
            <page-range>105-6</page-range>
            <pub-id pub-id-type="pmid">10651668</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30215.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hicks</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hing</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gao</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ryan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Macdonald</surname>
                <given-names>PS</given-names>
              </name>
            </person-group>
            <article-title>Organ preservation.</article-title>
            <source>Methods Mol Biol</source>
            <year>2006</year>
            <volume>333</volume>
            <fpage>331</fpage>
            <page-range>331-74</page-range>
            <pub-id pub-id-type="pmid">16790859</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30215.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Da Silva</surname>
                <given-names>IR</given-names>
              </name>
              <name>
                <surname>Frontera</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Worldwide barriers to organ donation.</article-title>
            <source>JAMA Neurol</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>72</volume>
            <issue>1</issue>
            <fpage>112</fpage>
            <page-range>112-8</page-range>
            <pub-id pub-id-type="pmid">25402335</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30215.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharma</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Roy</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Piscoran</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Summers</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>van Dellen</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Augustine</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Living donor kidney transplantation: Let's talk about it.</article-title>
            <source>Clin Med (Lond)</source>
            <year>2020</year>
            <month>May</month>
            <volume>20</volume>
            <issue>3</issue>
            <fpage>346</fpage>
            <page-range>346-348</page-range>
            <pub-id pub-id-type="pmid">32414729</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30215.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mathur</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Stewart Lewis</surname>
                <given-names>ZA</given-names>
              </name>
              <name>
                <surname>Warren</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Walters</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Gifford</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Xing</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Goodrich</surname>
                <given-names>NP</given-names>
              </name>
              <name>
                <surname>Bennett</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Brownson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ellefson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Felan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gray</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hays</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Klein-Glover</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lagreco</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Metzler</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Provencher</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Walz</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Warmke</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Merion</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Ojo</surname>
                <given-names>AO</given-names>
              </name>
            </person-group>
            <article-title>Best practices to optimize utilization of the National Living Donor Assistance Center for the financial assistance of living organ donors.</article-title>
            <source>Am J Transplant</source>
            <year>2020</year>
            <month>Jan</month>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>25</fpage>
            <page-range>25-33</page-range>
            <pub-id pub-id-type="pmid">31680449</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30215.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuypers</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Le Meur</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Cantarovich</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tredger</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Tett</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Cattaneo</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>T&#x000f6;nshoff</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Holt</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Chapman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gelder</surname>
                <given-names>Tv</given-names>
              </name>
              <collab>Transplantation Society (TTS) Consensus Group on TDM of MPA</collab>
            </person-group>
            <article-title>Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation.</article-title>
            <source>Clin J Am Soc Nephrol</source>
            <year>2010</year>
            <month>Feb</month>
            <volume>5</volume>
            <issue>2</issue>
            <fpage>341</fpage>
            <page-range>341-58</page-range>
            <pub-id pub-id-type="pmid">20056756</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30215.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shihab</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Christians</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wellen</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Kaplan</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Focus on mTOR inhibitors and tacrolimus in renal transplantation: pharmacokinetics, exposure-response relationships, and clinical outcomes.</article-title>
            <source>Transpl Immunol</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>31</volume>
            <issue>1</issue>
            <fpage>22</fpage>
            <page-range>22-32</page-range>
            <pub-id pub-id-type="pmid">24861504</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30215.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gaston</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>IMPROVING LONG-TERM OUTCOMES IN KIDNEY TRANSPLANTATION: TOWARDS A NEW PARADIGM OF POST-TRANSPLANT CARE IN THE UNITED STATES.</article-title>
            <source>Trans Am Clin Climatol Assoc</source>
            <year>2016</year>
            <volume>127</volume>
            <fpage>350</fpage>
            <page-range>350-361</page-range>
            <pub-id pub-id-type="pmid">28066070</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30215.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lefaucheur</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Loupy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zeevi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Complement-binding anti-HLA antibodies and kidney transplantation.</article-title>
            <source>N Engl J Med</source>
            <year>2014</year>
            <month>Jan</month>
            <day>02</day>
            <volume>370</volume>
            <issue>1</issue>
            <fpage>85</fpage>
            <page-range>85-6</page-range>
            <pub-id pub-id-type="pmid">24382075</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30215.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lefaucheur</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Viglietti</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bentlejewski</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Duong van Huyen</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Vernerey</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Aubert</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Verine</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jouven</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Legendre</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Glotz</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Loupy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zeevi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury.</article-title>
            <source>J Am Soc Nephrol</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>27</volume>
            <issue>1</issue>
            <fpage>293</fpage>
            <page-range>293-304</page-range>
            <pub-id pub-id-type="pmid">26293822</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30215.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kurian</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Gelbart</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mondala</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Head</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Horvath</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gaber</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Whisenant</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Langfelder</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Robison</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Schaffer</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Fisher</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Friedewald</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Flechner</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>LK</given-names>
              </name>
              <name>
                <surname>Wiseman</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Shidban</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mendez</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Heilman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Abecassis</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Marsh</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Salomon</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Molecular classifiers for acute kidney transplant rejection in peripheral blood by whole genome gene expression profiling.</article-title>
            <source>Am J Transplant</source>
            <year>2014</year>
            <month>May</month>
            <volume>14</volume>
            <issue>5</issue>
            <fpage>1164</fpage>
            <page-range>1164-72</page-range>
            <pub-id pub-id-type="pmid">24725967</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30215.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roedder</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sigdel</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Salomonis</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hsieh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dai</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bestard</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Metes</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Zeevi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gritsch</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cheeseman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Macedo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Peddy</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Medeiros</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vincenti</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Asher</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Salvatierra</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Shapiro</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kirk</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Reed</surname>
                <given-names>EF</given-names>
              </name>
              <name>
                <surname>Sarwal</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>The kSORT assay to detect renal transplant patients at high risk for acute rejection: results of the multicenter AART study.</article-title>
            <source>PLoS Med</source>
            <year>2014</year>
            <month>Nov</month>
            <volume>11</volume>
            <issue>11</issue>
            <fpage>e1001759</fpage>
            <pub-id pub-id-type="pmid">25386950</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30215.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ghiyasvandian</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zakerimoghadam</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Peyravi</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Nurse as a facilitator to professional communication: a qualitative study.</article-title>
            <source>Glob J Health Sci</source>
            <year>2014</year>
            <month>Nov</month>
            <day>16</day>
            <volume>7</volume>
            <issue>2</issue>
            <fpage>294</fpage>
            <page-range>294-303</page-range>
            <pub-id pub-id-type="pmid">25716406</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
